J Breast Cancer. 2009 Jun;12(2):117-120. English.
Published online Jun 30, 2009.
Copyright © 2009 Korean Breast Cancer Society
Case Report

A Mucocele-Like Tumor of the Breast Associated with Ductal Carcinoma In Situ and Mucinous Carcinoma: A Case Report

Jin Seong Cho, Hee Seon Ryu, Hye Won Ro, Hyo Soon Lim,1 Min Ho Park, Ji Shin Lee,2 Jung Han Yoon and Young Jong Jegal
    • Department of Surgery, College of Medicine, Chonnam National University, Gwangju, Korea.
    • 1Department of Radiology, College of Medicine, Chonnam National University, Gwangju, Korea.
    • 2Department of Pathology, College of Medicine, Chonnam National University, Gwangju, Korea.
Received September 11, 2008; Accepted March 31, 2009.

Abstract

A Mucocele-like tumor (MLT) of the breast is a rare lesion and is pathologically characterized by mucin-filled cysts and extravasated mucin present in the adjacent stroma. Since the first report of an MLT of the breast by Rosen in 1986, an MLT has been considered as part of a diverse spectrum of pathological lesions including benign tumors, atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and mucinous carcinomas. We described a case of an MLT of the breast associated with DCIS and a mucinous carcinoma in a 46-year-old female patient who was treated with a left modified radical mastectomy and a sentinel lymph node biopsy. This case supports the concept of a spectrum of pathological lesions for an MLT, including benign lesions, columnar hyperplasia, ADH, DCIS and mucinous carcinomas.

Keywords
Breast; Ductal Carcinoma in situ; Mucinous carcinoma; Mucocele-like tumor

INTRODUCTION

A Mucocele-like tumor (MLT) of the breast is a rare lesion, pathologically characterized by mucin-filled cysts and extravasated mucin presented in the adjacent stroma. Although the first report of Rosen(1) described this lesion as a benign entity, an MLT has been considered as a spectrum of various pathologic lesions, including benign tumor, atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS), and mucinous carcinomas.(2-5) Most invasive carcinomas that arise in this setting are of the mucinous type,(6) and some authors have postulated a morphologic and biologic continuum between an MLT and mucinous carcinomas.(7) We describe a rare case of an MLT of the breast associated with columnar cell hyperplasia, DCIS and mucinous carcinoma in a 46-yr-old female.

CASE REPORT

A 46-yr-old female presented with a palpable mass on left upper outer breast with no prior history of breast disease. The mammography showed a 1.8 cm equal density mass with punctuate microcalcification, a 0.9 cm size mass, and scattered microcalcifications in the upper to mid outer portion of the left breast. The ultrasonography (US) of breast showed an 1.8 cm size heterogeneously ill defined mass, a 0.9 cm size hypoechoic cystic lesion, and other multiple nodules in the left upper outer breast (Figure 1). A core needle biopsy of the associated mass lesion was subsequently performed and showed mucinous carcinoma. Magnetic resonance image (MRI) of breast showed multiple high signal intensity lesions in left upper outer breast on T2 weighted images, and dynamic contrast enhanced T1 weighted images revealed 0.6 cm and 1.7 cm size peripheral delayed enhancing lesions (Figure 2). Based on radiologic and pathologic results, we underwent mastectomy with sentinel lymph node biopsy approximately 1 month later.

Figure 1
A 0.9 cm size mucin-filled cystic lesion (mucocele like tumor) is adjacent to 1.8 cm size heterogeneous ill defined mucinous carcinoma on breast ultrasonography.

Figure 2
Multiple high signal intensity lesions in left upper outer breast on T2 weighted MR images, and subsequent dynamic contrast enhanced T1 weighted MR images revealed 0.6 cm and 1.7 cm size peripheral delayed enhancing lesions.

In this specimen we could see an MLT associated with columnar cell hyperplasia, micro papillary type DCIS, and mucinous carcinoma on histologic examination (Figure 3). All resection margins and 3 sentinel lymph nodes were free from tumor cell invasion or metastasis, and pathologic staging of mucinous carcinoma was T1cN0M0. Immunohistochemistry showed triple positive on estrogen receptor (ER), progesterone receptor (PR), and c-erbB2. And p53 and topoisomerase II-α were negative on immunochemical stain. Then she has been treated with GnRH analogue (Goserelin Acetate 3.6 mg, s.c, monthly) and estrogen antagonists (Tamoxifen 10 mg, b.i.d, daily), after operation. The patient is well-being without evidence of local or systemic recurrence.

Figure 3
A mucoele-like tumor with ductal carcinoma in situ (DCIS) and mucinous carcinoma (A). Low magnification view showing mucin-filled epithelial lined cysts and extravasated mucin in the stroma (B). Columnar cell epithelium in the cyst (C). Micropapillary DCIS (D). Low magnification view showing mucinous carcinoma (A, D, H&E stain).

DISCUSSION

The pathogenesis of an MLT of the breast is still uncertain. In 1986, Rosen suggested that excess production of mucin or ductal obstruction may be contributing factors and then minor trauma is probably sufficient to cause rupture of distended cysts or ducts and extravasation of the mucin.(1) Subsequent studies have confirmed the diverse spectrum of pathologic lesions of an MLT, including benign lesions, ADH, DCIS, and mucinous carcinomas.(2-9) Some authors have postulated a morphologic and biologic continuum between an MLT and mucinous carcinomas.(7) Fine-needle aspiration cytology of benign mucocele-like tumor may be difficult to distinguish from mucinous carcinoma. It is important, therefore, to exclude the possibility of carcinoma by examining adequate tissue samples when an MLT was found in a breast biopsy. Excisional biopsy is required for an accurate diagnosis. In this case, we sampled only mucinous carcinoma through core needle biopsy specimen, and subsequent permanent histologic examination showed an MLT associated with columnar cell hyperplasia, micro-papillary type DCIS, and mucinous carcinoma (Figure 3).

Mammographic appearances of MLTs are indeterminate microcalcifications or a nodule, often containing calcifications.(10, 11) In the malignant MLTs, the calcifications extended over a wider area than the calcifications in the benign MLTs.(10) but in this case, we can see the some scattered microcalcifications. Sonographic appearances of cysts with calcified or noncalcified nodules, often multiple, may suggest the diagnosis of MLTs, but the appearance does not help to differentiate between benign and malignant MLTs.(11, 14)

Surgical excision is recommended for a benign MLT, and breast-conserving surgery is appropriate therapy for an MLT with carcinoma. Axillary nodal metastasis of an MLT has not been reported,(8, 13) and axillary lymph node dissection may be unnecessary. Radiation therapy is indicated if a carcinoma involves margins or if extensive intraductal carcinoma is present.(2, 4-8, 13) In this case, she has been treated with GnRH analogue (Goserelin Acetate 3.6 mg, s.c, monthly) and estrogen antagonists (Tamoxifen 10 mg, b.i.d, daily), after operation but has not been treated with radiation therapy.

There were no appreciable differences in age, tumor size, or laterality between patients with a benign MLT or malignant one, although an MLT with carcinoma had coarse calcification more often than benign MLT.(8) Retrospective analyses have suggested that an MLT may represent a marker of a slightly increased risk for the subsequent development of invasive carcinoma when they are identified in a biopsy.(12)

We describe a case of an MLT of the breast associated with DCIS and mucinous carcinoma in a 46-yr-old female who was treated with modified radical mastectomy and hormone therapy. This case supports the concept that MLTs encompasses a spectrum of pathologic lesions including benign tumor, ADH, DCIS and mucinous carcinoma.

References

    1. Rosen PP. Mucocele-like tumors of the breast. Am J Surg Pathol 1986;10:464–469.
    1. Ro JY, Sneige N, Sahin AA, Silva EG, Del Junco GW, Ayala AG. Mucocele-like tumors of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. Arch Pathol Lab Med 1991;115:137–140.
    1. Yeoh GP, Cheung PS, Chan KW. Fine-needle aspiration cytology of mucocele-like tumors of the breast. Am J Surg Pathol 1999;23:552–559.
    1. Kulka J, Davies JD. Mucocele-like tumors: more associations and possibly carcinoma in situ? Histopathology 1993;22:511–512.
    1. Fisher CJ, Millis RR. A mucocele-like tumor of the breast associated with both atypical ductal hyperplasia and mucoid carcinoma. Histopathology 1992;21:69–71.
    1. Lee JS, Kim HS, Jung JJ, Lee MC. Mucocele-like tumor of the breast associated with ductal carcinoma in situ and mucinous carcinoma: a case report. J Korean Med Sci 2001;16:516–518.
    1. Chinyama CN, Davies JD. Mammary mucinous lesions: congeners, prevalence and important pathological associations. Histopathology 1996;29:533–539.
    1. Hamele-Bena D, Cranor ML, Rosen PP. Mammary mucocele-like lesions. Benign and malignant. Am J Surg Pathol 1996;20:1081–1085.
    1. Weaver MG, Abdul-Karim FW, al-Kaisi N. Mucinous lesions of the breast. A pathological continuum. Pathol Res Pract 1993;189:873–876.
    1. Kim JY, Han BK, Choe YH, Ko YH. Benign and malignant mucocele-like tumors of the breast: mammographic and sonographic appearances. Am J Roentgenol 2005;185:1310–1316.
    1. Glazebrook K, Reynolds C. Mucocele-like tumors of the breast: mammographic and sonographic appearances. AJR Am J Roentgenol 2003;180:949–954.
    1. Martel M, Barron-Rodriguez P, Tolgay Ocal I, Dotto J, Tavassoli FA. Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999). Virchows Arch 2007;451:883–891.
    1. Cardenosa G, Doudna C, Eklund GW. Mucinous (colloid) breast cancer: clinical and mammographic findings in 10 patients. AJR Am J Roentgenol 1994;162:1077–1079.
    1. Kim Y, Takatsuka Y, Morino H. Mucocele-like tumor of the breast: a case report and assessment of aspiration cytological specimens. Breast Cancer 1998;5:317–320.

Cited by
Metrics
Share
Figures

1 / 3

PERMALINK